Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance)
- PMID: 30038051
- PMCID: PMC6170705
- DOI: 10.1158/1055-9965.EPI-18-0487
Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance)
Abstract
Background: Higher intake of long-chain ω-3 polyunsaturated fatty acids and nuts, rich plant sources of unsaturated fats, after colon cancer diagnosis are associated with improved survival. It is not known whether the amount or the distribution of other types of fat is associated with survival after colon cancer.Methods: We prospectively examined postdiagnostic total, animal, and vegetable fats, as well as the saturated, monounsaturated, polyunsaturated, and trans fat in relation to disease-free survival among 1,011 patients with stage III colon cancer. Patients were enrolled between 1999 and 2001 at the onset of adjuvant chemotherapy and followed for recurrence or death through 2009.Results: During median follow-up of 7 years, we observed 305 deaths and 81 recurrences (total events: 386). Neither total nor any specific type of dietary fat examined was statistically significantly associated with risk of cancer recurrence or death from any cause (disease-free survival) after stage III colon cancer.Conclusions: The amount and type (animal, vegetable, saturated, monounsaturated, polyunsaturated, and trans) of dietary fat consumed after colon cancer does not appear to be substantially associated with risk of recurrence or survival.Impact: Neither total nor major types (animal, vegetable, saturated, monounsaturated, polyunsaturated, and trans) of dietary fat consumed after colon cancer was associated with cancer recurrence or survival. Cancer Epidemiol Biomarkers Prev; 27(10); 1227-30. ©2018 AACR.
Trial registration: ClinicalTrials.gov NCT00003835.
©2018 American Association for Cancer Research.
Conflict of interest statement
References
-
- Van Blarigan EL, Fuchs CS, Niedzwiecki D, Ye X, Zhang S, Song M, et al. Marine omega-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance). Cancer Epidemiol Biomarkers Prev 2018;27(4):438–45 doi 10.1158/1055-9965.EPI-17-0689. - DOI - PMC - PubMed
-
- Saltz LB, Niedzwiecki D, Hollis D, Goldberg RM, Hantel A, Thomas JP, et al. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3456–61 doi 10.1200/JCO.2007.11.2144. - DOI - PubMed
-
- Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135(10):1114–26; discussion 27–36. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- R35 CA197735/CA/NCI NIH HHS/United States
- R01 CA118553/CA/NCI NIH HHS/United States
- R01 CA149222/CA/NCI NIH HHS/United States
- UG1 CA189974/CA/NCI NIH HHS/United States
- U10 CA180821/CA/NCI NIH HHS/United States
- K07 CA197077/CA/NCI NIH HHS/United States
- UG1 CA189858/CA/NCI NIH HHS/United States
- UG1 CA233180/CA/NCI NIH HHS/United States
- U10 CA180882/CA/NCI NIH HHS/United States
- U10 CA180820/CA/NCI NIH HHS/United States
- U10 CA180867/CA/NCI NIH HHS/United States
- U10 CA138561/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- U10 CA180791/CA/NCI NIH HHS/United States
- K99 CA215314/CA/NCI NIH HHS/United States
- R00 CA215314/CA/NCI NIH HHS/United States
- U10 CA180888/CA/NCI NIH HHS/United States
- P50 CA127003/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical